Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction
Authors:
- Rasmus Sejersten RipaRRRasmus Sejersten Ripa
- Julia S. JohansenJJJulia S. Johansen
- Erik JørgensenEJErik Jørgensen
- Jens KastrupJKJens Kastrup
- 27 January 2010
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 70 (2) , 80-86
Abstract
Background: Plasma YKL-40 is increased early in patients with ST-elevation myocardial infarction (STEMI). It is not known whether plasma YKL-40 is related to infarct size and recovery of ventricular function after primary percutaneous coronary intervention (PCI) of STEMI and whether granulocyte colony-stimulating factor (G-CSF) therapy influence plasma YKL-40 concentration. Materials and methods: A total of 72 patients (age: 56 ± 9 years (mean ± SD), 56 men and 16 women) with STEMI treated with PCI were included in a double-blind, randomized, placebo-controlled trial with subcutaneous G-CSF or placebo injections from day 1 to 7 after the STEMI. Plasma YKL-40, high-sensitivity C-reactive protein (hs-CRP) and CK-MB concentrations were measured at baseline and during the first month. Infarct size and left ventricular ejection fraction (LVEF) were measured by magnetic resonance imaging at baseline and after 6 months. Results: Baseline plasma YKL-40 was increased (median 92 μg/L) compared to healthy subjects (median 34 μg/L, p p = 0.04) and day 3 (p = 0.01), but not at day 7 and 30. Moreover, YKL-40 correlated negatively to LVEF recovery (p = 0.04) but not infarct size. G-CSF injections increased YKL-40 compared to placebo (p Conclusion: Plasma YKL-40 was significantly increased in STEMI patients at admission and G-CSF treatment caused a further increase in YKL-40. Plasma YKL-40 may be an indirect marker of LVEF recovery, independent of hs-CRP, and higher plasma YKL-40 indicates a lower recovery.Keywords
This publication has 31 references indexed in Scilit:
- High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery diseaseEuropean Heart Journal, 2009
- G-CSF therapy with mobilization of bone marrow stem cells for myocardial recovery after acute myocardial infarction—A relevant treatment?Experimental Hematology, 2008
- Experimental anti‐angiogenesis causes upregulation of genes associated with poor survival in glioblastomaInternational Journal of Cancer, 2007
- A Chitinase-like Protein in the Lung and Circulation of Patients with Severe AsthmaNew England Journal of Medicine, 2007
- Exoskeletons and ExhalationNew England Journal of Medicine, 2007
- Evolution of Mammalian Chitinase(-Like) Members of Family 18 Glycosyl HydrolasesGenetics, 2007
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Regulation of YKL‐40 expression during genotoxic or microenvironmental stress in human glioblastoma cellsCancer Science, 2005
- Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarctionThe American Journal of Cardiology, 2004
- Inflammation and AtherosclerosisCirculation, 2002